JITSUBO
JITSUBO aims to be a Peptide Lowest Cost Producer by continuously improving core technologies by incorporating all the latest technologies. JITSUBO company name is derived from "Chiba Jitsubo-san", a family business of Kazuhiro Chiba, a science and technology adviser and co-founder. Chiba Minorusan is a rare medicine that has been contributing to the health of people for over 500 years as a herbal medicine for women. The company named 'JITSUBO' from the desire to provide products that are useful for people's health through peptide drugs for a long time. We aim to be such a great mother-like company that continues to bring the results of technological innovation to the value of superior peptide drugs and continue to produce them in society.
JITSUBO
Industry:
Chemical Embedded Systems Medical Nursing And Residential Care
Founded:
2008-04-08
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.jitsubo.com
Total Employee:
11+
Status:
Active
Contact:
045-633-4327
Total Funding:
2.5 B JPY
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins
Current Employees Featured
Founder
Investors List
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Venture Round - JITSUBO
Sosei Group
Sosei Group investment in Venture Round - JITSUBO
Universal Materials Incubator
Universal Materials Incubator investment in Venture Round - JITSUBO
World Innovation Lab (WiL)
World Innovation Lab (WiL) investment in Venture Round - JITSUBO
SMBC Venture Capital
SMBC Venture Capital investment in Venture Round - JITSUBO
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) investment in Venture Round - JITSUBO
Shinsei Corporate Investment
Shinsei Corporate Investment investment in Venture Round - JITSUBO
Official Site Inspections
http://www.jitsubo.com Semrush global rank: 6.08 M Semrush visits lastest month: 448
- Host name: 157-7-107-56.virt.lolipop.jp
- IP address: 157.7.107.56
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "JITSUBO"
JITSUBO株式会社 | ペプチドで、未来の笑顔を創造しよう
私たちJITSUBOは、高品質で環境に優しく、圧倒的なコスト優位性を目指した ペプチド医薬品原薬の研究開発に取り組んでい ...See details»
About Jitsubo | Jitsubo CO.,LTD.
Jan 14, 2020 He joined Jitsubo in 2017 as a board member and became Executive Vice President in December 2019. Prior to Jitsubo, he held management positions in companies, Director, Universal Materials Incubator …See details»
JITSUBO - Crunchbase Company Profile & Funding
JITSUBO is a manufacturing company that develops peptide synthesis, pharmaceutical ingredients, and offers technology licensing services.See details»
Jitsubo CO.,LTD. | Development of peptide …
Jitsubo announces signing of Exclusive Manufacturing License Agreement in the field of Diabetes, Obesity and the Related Therapeutic Areas with Novo NordiskSee details»
Jitsubo Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Jitsubo. Use the PitchBook Platform to explore the full profile.See details»
JITSUBO CO., LTD. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for JITSUBO CO., LTD. of YOKOHAMA, KANAGAWA. Get the latest business insights from Dun & Bradstreet.See details»
Jitsubo Company Profile | Management and Employees List
Find contact information for Jitsubo. Learn about their Chemicals & Related Products, Manufacturing market share, competitors, and Jitsubo's email format.See details»
JITSUBO - Contacts, Employees, Board Members, Advisors & Alumni
JITSUBO is a manufacturing company that develops peptide synthesis, pharmaceutical ingredients, and offers technology licensing services.See details»
Jitsubo Co., Ltd.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Jitsubo Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 literature, Drug:JIT-8012.See details»
Jitsubo - Company Profile - Tracxn
Nov 5, 2024 Jitsubo - Japanese, preclinical-stage, drug discovery company developing peptide-based therapeutics. Acquired by Sosei. Raised a total funding of $23.2M over 1 round from 3 …See details»
Jitsubo Company Profile - Office Locations, Competitors, Revenue ...
Jitsubo has 1 employees at their 1 location and $23.56 m in total funding,. See insights on Jitsubo including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
JITSUBO - Funding, Financials, Valuation & Investors
JITSUBO is a manufacturing company that develops peptide synthesis, pharmaceutical ingredients, and offers technology licensing services.See details»
CEO message | Jitsubo CO.,LTD.
CEO message Peptides are widely used as one of very important active pharmaceutical ingredients for anticancer drugs, therapeutic agents for gynopathy, metabolic diseases such …See details»
Jitsubo - Overview, News & Similar companies | ZoomInfo.com
View Jitsubo (www.jitsubo.com) location in Kanagawa, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
JITSUBO - STARTUP DB｜スタートアップデータベース
ペプチド合成法「Molecular Hiving」の開発を行っている企業。 2021年4月7日に全株式をスペラファーマに譲渡し、子会社となった。See details»
JITSUBO - Tech Stack, Apps, Patents & Trademarks
JITSUBO is a manufacturing company that develops peptide synthesis, pharmaceutical ingredients, and offers technology licensing services.See details»
Contact | Jitsubo CO.,LTD.
2023.04.13 Exhibiting at CPHI Japan 2023 2023.06.15 Jitsubo announces signing of Exclusive Manufacturing License Agreement in the field of Diabetes, Obesity and the Related …See details»
Bachem partners with Jitsubo on Molecular Hiving™
Jun 2, 2020 Jitsubo CEO Dr. Kazuaki Kanai commented: “It is a great pleasure for us having collaborated with the industry leader, Bachem, in exploring applications of our unique …See details»
NEWS | Jitsubo CO.,LTD.
Jitsubo CO., LTD. announced the signing of an exclusive manufacturing license agreement with Novo Nordisk A/S（2880 Bagsvaerd, Denmark, hereinafter “Novo Nordisk”）for Novo Nordisk …See details»
Bachem and Jitsubo enter into exclusive Licensing Agreement
Bubendorf/Basel, Switzerland and Yokohama, Japan, May 8, 2020 – Bachem (SIX: BANB) and Jitsubo CO., LTD. announce today that they signed an exclusive Licensing Agreement for …See details»